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Stroke is the second leading cause of death
worldwide. The aim of treatment in stroke patients is to
prevent further neurologic deterioration and prevent
recurrence.  Despite all advances in medical treatment,
morbidity and mortality in stroke patients is still very high.
The other alternative is surgical treatment, which still lacks
class 1 evidence. However there is recent reconsideration of
this form of treatment and ongoing trials are showing some
promising results. In this review the recent advances in
surgical treatment of stroke will be discussed along with
recommendations from the latest randomized trials.
Introduction
Stroke is the second leading cause of death
worldwide.1 The World Health Organization defines stroke
clinically as "rapidly developing clinical signs of focal
disturbance of cerebral function, lasting for more than
twenty four hours or leading to death.1 We can divide stroke
into two broad categories namely, ischaemic stroke and
haemorrhagic stroke. Ischaemic stroke or cerebral infarction
is the most common, accounting for approximately 70-80%
of all strokes.2 Spontaneous intracranial haemorrhages
account for about 20% of all strokes, but they are often
devastating, accounting for a disproportionately large
proportion of morbidity and mortality among stroke
patients. Haemorrhagic stroke comprises of two main types;
intraparenchymal haemorrhage (ICH), where there is
bleeding within the brain itself and subarachnoid
haemorrhage (SAH), which is characterized by vessel
rupture in the cerebrospinal fluid filled subarachnoid space
surrounding the brain.3
The aim of treatment in stroke patients is to prevent
further neurological deterioration and prevent recurrence.
Strokes can have minor consequences especially lacunar
and small cortical strokes or they can be lethal if they
involve major arterial distribution such as whole middle
cerebral artery (MCA) territory infarction (Figure 1).
Despite all advances in medical treatment, mortality in such
large infarcts is estimated to be between 50% and 78%.4 The
other alternative is surgical treatment, which still lacks class
1 evidence. However there is recent reconsideration of this
form of treatment and ongoing trials are showing some
promising results. In this review the recent advances in
surgical treatment of stroke along with recommendations
from latest randomized trials will be discussed.
Surgical treatment of ischaemic stroke: 
The poor outcome associated with ischaemic stroke
is attributed to malignant oedema that causes early rise in
intracranial pressure (ICP) and subsequent brain herniation
and death.5 Current available medical treatment of
ischaemic stroke includes thrombolysis and anti
coagulation. To deal with the lethal complication of
malignant oedema and raised ICP, medical treatment offers
mannitol, hypertonic saline, barbiturate coma, hypothermia
and hyperventilation. However no medical therapy has
proven effective in preventing brain herniation and
improving patient outcome.6
Decompressive Craniectomy: As an alternative
therapy, surgical decompression techniques have been
proposed to relieve the high ICP. This involves removal of
large bone flap, Ipsilateral to the side of infarction
(hemicraniectomy) followed by dural reconstruction with
the help of the flap taken from temporal fascia or any other
available graft (duroplasty).7 No attempt is made to remove
the necrotic infarcted brain parenchyma. The rationale of
this therapy is to create compensatory space to
accommodate the swollen brain, thereby normalizing
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Figure 1. CT Brain showing large right MCA territory infarct with significant midline shift and
mass effect.
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intracranial pressure, reverting brain shifts and preventing
secondary neuronal insult.
Decompressive surgery was first reported as a
potential treatment for large hemispheric infarction in case
reports as early as 1956.7 The largest case series suggested
that early decompression reduces mortality and may
provide improved outcomes by avoiding the consequences
of brainstem compression from transtentorial herniation.
Patients who underwent early hemicraniectomy had a
mortality rate of 16% compared to 34% for delayed
surgery.8 But this form of treatment remains controversial in
the absence of randomized controlled trials.
Recently three multicentre randomized controlled
trials have been conducted with favourable outcomes in
patients who underwent decompressive craniectomies for
the treatment of large MCA ischaemic strokes. These are
DESTINY (Decompressive Surgery for the Treatment of
Malignant Infarction of the Middle Cerebral Artery) from
Germany, DECIMAL (Decompressive Craniectomy In
Middle Cerebral Artery Infarcts) from France and
HAMLET (Hemicraniectomy After Middle Cerebral Artery
Infarction With Life Threatening Odema Trial) from
Netherland.9
DESTINY is a prospective, multicentre,
randomized, controlled, clinical trial based on a sequential
design that used mortality after 30 days as the first end
point.10 When this end point was reached, patient
enrollment was interrupted as per protocol. A statistically
significant reduction in mortality was reached after 32
patients had been included. Fifteen of seventeen (88%)
patients randomized to hemicraniectomy versus 7 of 15
(47%) patients randomized to conservative therapy survived
after 30 days (P = 0.02). After 6 and 12 months, 47% of
patients in the surgical arm versus 27% of patients in the
conservative treatment arm had a modified Rankin Scale
score of 0 to 3 (P = 0.23). DESTINY showed that
hemicraniectomy reduces mortality in large hemispheric
stroke. DESTINY has several shortcomings. First, 81% of
patients originated from 2 centres only. As a matter of fact,
this makes DESTINY an oligocentre rather than a
multicentre trial. In addition DESTINY does not provide
data on older patients with malignant MCA infarction.
Based on the results of several reports suggesting that
patients more than 60 years may not benefit from
decompressive surgery, DESTINY only included patients
18 to 60 years of age.
DECIMAL is a Sequential-Design trial conducted in
France involving patients between 18 and 55 years of age
with malignant MCA infarction to compare functional
outcomes with or without decompressive craniectomy.6
After randomization of 38 patients, the data safety
monitoring committee recommended stopping the trial
because of slow recruitment and organizing a pooled
analysis of individual data from this trial and the two other
ongoing European trials of decompressive craniectomy in
malignant MCA infarction. Among the 38 patients
randomized, the proportion of patients with a MRS score
less than 3 at the 6-month and 1-year follow-up, was 25%
and 50%, in the surgery group compared with 5.6% and
22.2%, in the no-surgery group respectively (P = 0.18 and P
= 0.10, respectively). There was a 52.8% absolute reduction
of death after craniectomy compared with medical therapy
only (P<0.0001). In this trial, early decompressive
craniectomy increased by more than half the number of
patients with minimal to moderate disability and
significantly reduced (by more than half) the mortality rate
compared with that after medical therapy.
The other surgical options for ischaemic stroke are
embolectomy, carotid endartrectomy, stenting and
emergency revascularization. The National Institute of
Neurological Disorders and Stroke (NINDS) reported that
thrombolytic therapy by intravenous administration of a
recombinant tissue plasminogen activator (t-PA) was
effective in improving the prognosis of patients with acute
cerebral infarction within 3hours after the onset.11 However,
cases of cerebral infarction due to main-trunk occlusion had
a low revascularization rate and a poor prognosis.12
Carotid endarterectomy: Carotid artery surgery
has been shown to significantly decrease the risk of a
subsequent stroke compared to the best medical therapy
alone.13 Carotid artery surgery has also been used when the
patient has acute carotid occlusion and minor stroke.
Possible contraindications to carotid endarterectomy
include serious medical risks of anaesthesia and recent large
parenchymal infarction.
Carotid artery surgery helps prevent subsequent
brain ischaemia secondary to haemodynamic insufficiency,
arterial embolism or propagating thrombosis from the
diseased artery. The benefits of carotid surgery appear to be
durable. Recurrent stenosis occurs at the rate of 5 - 10% per
year after operation but is not always symptomatic.14
Operative mortality is less than 2% and the risk of stroke is
less than 4%.15
Prospective analyses as the North American
Symptomatic Carotid Endarterectomy Trial (NASCET), the
Asymptomatic Carotid Atherosclerosis Study (ACAS), and
the European Carotid Surgery Trial (ECST) demonstrated
superior reduction in the incidence of stroke among
symptomatic and a select group of asymptomatic patients
undergoing carotid endarterectomy (CEA). These studies
established CEA as the therapeutic gold standard for
symptomatic carotid atherosclerosis.
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However technical innovations in interventional
radiology have renewed the debate about the optimal
therapy. Although retrospective analyses of angioplasty and
stenting suggest that their clinical efficacy is comparable to
that of endarterectomy, prospective evaluation is pending.
The Carotid Revascularization Endarterectomy versus Stent
Trial (CREST) and the Carotid and Vertebral Artery
Transluminal Angioplasty Study (CAVATAS) will attempt
to address the efficacy of percutaneous angioplasty and
stenting compared with CEA. 
Revascularization surgery: Bypass surgery provides
collateral blood flow to the territory of occluded or severely
stenosed cerebral arteries. A large international cooperative
study, however, failed to reveal any benefit of external
carotid - internal carotid artery (EC-IC) bypass surgery,
usually done by end to side anastomosis of superficial
temporal artery branch with middle cerebral artery distal to
pathological site, in the setting of symptomatic arterial
occlusions and inaccessible stenosis.16 However two
particular groups were not addressed: those for whom the
best available medical therapy had failed and those with
clearly documented haemodynamic compromise.17
The current indications of revascularization surgery
include patients with impaired collaterals causing regional
cerebral blood flow compromise and failed maximal
medical therapy. Other clinical situations in which an EC-IC
bypass procedure may be considered includes, giant
cerebral aneurysms not amenable to direct surgical clipping
and reconstruction (where the parent vessel must be
sacrificed) and other progressive vasculopathies.
Sakai et al reported their surgical results in patients
with acute cerebral main-trunk occlusion in the anterior
circulation.18 Twenty six patients were surgically treated
within 24 hours after the onset. The occlusion occurred in
the internal carotid artery in 10 patients, in the middle
cerebral artery in 15 patients, and in the anterior cerebral
artery in 1 patient. Nine patients underwent anastomosis, 14
had an embolectomy, and 3 had a carotid endarterectomy. In
all the patients, revascularization was achieved, and
neurological improvement was obtained. Their study
concluded that early surgical revascularization can be an
effective and safe treatment modality in appropriately
selected patients with acute cerebral main-trunk occlusion
in the anterior circulation.
Revascularization in Moya Moya Disease:
Moyamoya disease (MMD) is a rare cerebrovascular
condition characterized by progressive, idiopathic occlusion
of the bilateral supraclinoid internal carotid arteries (ICA),
proximal middle cerebral artery, and anterior cerebral artery
(ACA). Since its first description by Takeuchi and Shimizu
in 1957 and subsequent angiographic characterization and
naming by Suzuki and Takaku in 1969, several thousand
cases have been documented worldwide. Moyamoya
disease is diagnosed and staged by using catheter
angiography.
With a morbidity rate of >70% in untreated patients,
surgical intervention has become the standard therapy in
patients with MMD. Surgical interventions have been
divided into direct and indirect bypass techniques. The
direct bypass techniques proposed include superficial
temporal artery - middle cerebral artery (STA-MCA),
occipital artery-MCA, and middle meningeal artery- middle
cerebral artery (MMA-MCA) anastomoses. The indirect
techniques consist of multiple cranial bur holes, omental
transposition, encephaloduroarteriosynangiosis (EDAS)
and encephaloduroarteriomyosynangiosis (EDAMS), both
consist of laying dural flap with intact blood supply directly
on to cerebral cortex.
Surgical treatment of haemorrhagic stroke
Intra parenchymal brain haemorrhage is more
common than sub arachnoid haemorrhage as a cause of
stroke. Sub-arachnoid haemorrhage itself may not require
any surgical treatment but some of its causes or
complications require surgery. Aneurysms causing sub
arachnoid haemorrhage require obliteration by clipping or
coiling. Vascular malformations may require surgical
excision. Hydrocephalus or malignant oedema developing
after sub-arachnoid hemorrhage may also require surgery.
The first question that a surgeon has to address while
treating a case of ICH is whether or not surgery is required
in a particular case?  The answer to this question is better
defined in the case of infra-tentorial haematomas than in
supra-tentorial clots. 
Surgery is required in cerebellar haematomas if there
is tight posterior fossa, moderate to severe compression of
fourth ventricle, hydrocephalus or a Glasgow coma score of
less than 13. Size of the haematoma is a more controversial
issue. Vermian haematomas more often require evacuation
as compared to hemispheric hematomas of comparable size.
Surgery is required for a hemispheric hematoma which is 40
x 30 mm or more and a vermian hematoma which is 35 x 25
mm or more in their largest dimensions. However, a
hemispheric haematoma can be observed and managed
conservatively, even if it is more than 30 mm in its
maximum diameter but is not causing any significant
compression of the fourth ventricle.19,20 Similarly prognosis
for brain stem haematomas is poor except in those cases of
pontine haemorrhage that are not comatose to begin with,
have normal pupils and the size of the haematoma is less
than 20 mm.21 The results of surgery were found to be
favorable in 13 out of 20 patients with CT guided
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stereotactic aspiration of pontine tegmental hypertensive
haemorrhages when compared to the conservative
treatment.22
The indications of surgery in supra-tentorial ICH are
less obvious. This may be because of a paucity of large,
randomized, multi-centre studies. Another reason is
probably a trend towards minimally invasive surgery with
resultant modification of the indications. The only large,
randomized, multicentre study addressing this issue is
International Surgical Trial for Intra Cerebral Haemorrhage
(STICH).23 In this trial 1033 patients from 83 centres in 27
countries mainly from Europe, Asia and Africa were
randomized into two treatment groups. In one group,
patients were managed conservatively, while in the other
group patients underwent surgery within 24 hours of
randomization in addition to conservative treatment.
Variables were age, haematoma volume, Glasgow coma
score, lobar versus basal ganglia / thalamic haematoma or
both, thrombolytic or anticoagulant treatment, severity of
neurological deficit and type of intended operation.
Prognostic score was calculated as:
(10 x admission Glasgow coma score) - Age (years) -
(0.64 x volume [ml])
Primary outcome was death or disability using the
extended Glasgow outcome scale 6 month after the ictus.
Secondary outcome included mortality, the Barthel index
and the modified Rankin scale. Significant benefit of
surgery was not found in terms of mortality, modified
Rankin scale or Barthel index. Any favorable outcome seen
with minimally invasive methods was offset by the
craniotomy procedures, which were performed in the
majority of the patients. This majority of craniotomies are
probably the reason why the only advantage of early surgery
observed in this study is for the hematomas located within
one centimeter of the surface (easier removal of superficial
hematomas through craniotomies). Results of other
randomized trials before STICH also failed to show any
benefit of surgery in ICH.23 Does that prove that there are
no well defined indications for surgery in supra tentorial
ICH? The answer to this question lies in the inclusion
criteria of STICH trial. One of the inclusion criteria for this
trial is "if the responsible neurosurgeon is uncertain about
the benefits of either treatment". So the uncertain results
attest to the "uncertainty" of the surgeons. This means that
there should be a number of cases in which a surgeon is
more certain about the results of surgery. This leads to
another question. When should a surgeon be more certain
about the decision to operate in a case of supra tentorial
ICH? Although there is no support from the literature, no
one can wait in a middle aged otherwise fit patient who
shows rapid deterioration of level of consciousness due to a
relatively superficial medium size (15-30 cc) clot located in
a non eloquent part of the brain. So the best indication of
surgery in supra-tentorial hematomas is certainty of the
surgeon about the results of surgery according to his/her
knowledge, experience and circumstances.
The methods for hematoma evacuation can be
divided into two categories: craniotomy / craniectomy and
minimally invasive procedures. 
Craniotomy: In STICH trial, craniotomy and
evacuation of ICH has been found to be associated with
favorable outcome for the hematomas within 1 cm of the
brain surface (Figure 3). The other theoretical consideration
is the consistency of the hematoma. A more organized
Figure 3. CT Brain showing large left basal ganglia bleed with mass effect and intraventricular
spillage of blood. Surgery offered as a life saving procedure after patient developed signs of
herniation. a - Preop scan, b - post op scan.
3a
3b
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hematoma should be easily evacuated through craniotomy
but is resistant to suction without fibrinolysis if operated by
minimally invasive procedures. Visibility provided by the
combination of craniotomy and operating microscope may
be another advantage over blind procedures which form a
significant part of minimally invasive surgery. However, a
deep seated hematoma in clinically good patients should be
observed (Figure 2).
One study from China has prospectively compared
endoscopic surgery, stereotactic aspiration and craniotomy
in non comatose patients.24 The three randomized treatment
groups (with 30 patients in each group) were compared with
respect to waiting time of surgery, length of operation time,
blood loss, hematoma evacuation rate and mortality.
Neurological outcome was compared with respect to
functional independence measure (FIM) score, Barthel
index score and muscle power (MP) of affected limbs 6
months after surgery. Stereotactic aspiration had the longest
waiting time before evacuation (172.56 +/- 93.18 minutes;
P<001). This makes it less suitable for urgent situations.
Craniotomy had the longest operating time (229.96 +/-
50.57 minutes; P < .001), with most significant blood loss
(236.13 +/-137.45 ml; P<0.001), highest mortality (13.3%)
and highest complication rate (16.6%). The most major
complications were re bleeding and infection. The FIM
score, Barthel index and improvement in muscle power
were significantly better in endoscopy group as compared to
craniotomy group. Therefore, depending upon the
availability and urgency of the situation endoscopic
evacuation of the hematoma is preferable over craniotomy. 
Decompressive Craniectomy: Not much is
available on this topic in the literature. A retrospective study
from India has reviewed 12 patients who were treated with
decompressive hemicraniectomy with evacuation of
hypertensive ICH.25 Interestingly 11 out of 12 patients were
discharged alive. Three out of seven with pupillary
abnormalities, 7 of 11 with intra ventricular extension of
haematoma and 4 of 8 with haematoma volume greater than
60 cc made good functional recovery. All these are
considered to be bad prognostic signs. Therefore
decompressive hemicraniectomy with clot evacuation can
be life saving with good functional outcome in patients with
a large size ICH is extending into the ventricles and is
associated with papillary abnormalities.
Minimally Invasive Surgery: This can be described
in two broad categories namely blind procedures and
endoscopy.  
Blind Procedures: Blind procedures are essentially
burr hole aspirations, with or without the help of stereotaxy
and fibrinolysis. Stereotaxy adds precision to the procedure
while fibrinolysis makes a clot of firm consistency more
amenable to suction. Fibrinolysis may be chemical e.g. with
urokinase or t-PA or mechanical e.g. with Archimedes
screw, ultrasonic aspirator or oscillating cutters. Outcome
after fibrinolytic stereotactic evacuation of clot may be
comparable to other methods of treatment. It is particularly
advantageous for deep seated lesions.26 In a study
evaluating stereotactic treatment of intra cerebral
haematoma by means of a plasminogen activator (SICHPA)
randomized 70 patients in two groups. In surgical group a
stereotactically placed catheter was used to instill urokinase
to liquefy and drain the ICH in 6 hourly intervals over 48
hours. In other group the patients were treated
conservatively. There was no difference in mortality as well
as functional outcome. The only difference was better
reduction of haematoma volume over 7 days.27 Studies have
also compared the results of frame based and frameless
stereotaxy for the evacuation of supra tentorial ICH. No
difference has been found between the two techniques with
respect to haematoma volume reduction or outcome.28,29
Neuroendoscopy: Neuroendoscopy has been found
to be better than the stereotaxy and craniotomy for the
evacuation of basal ganglia ICH in non comatose patients.24
Neuroendoscopic evacuation of intra ventricular
haemorrhage, when compared to external ventricular
drainage alone, was found to be associated with better
functional outcome; however, there was no difference in
mortality.30 The surgical technique becomes less invasive
with the use of neuroendoscope. A smaller bony opening is
required to accommodate a cortical incision, which is
usually less than a centimeter in width.31 Use of a metallic
tube allows both endoscope as well as other instruments to
be used through the tube at the same time. The tube can be
Figure 2. CT Brain showing small deep seated right basal ganglia bleed. Managed non operatively
by Neuro observation. 
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manoeuvred in different directions. Instead two separate
burr holes can be used for the same purpose. Liquid part of
the haematoma can be aspirated. More solid part requires
dissection and piecemeal removal. Dissection can be done
with the help of a metallic instrument separate from the
endoscope or it can also be performed with the help of a
transparent viewing dissector coupled with endoscope. A
water jet can also perform dissection of the haematoma.
Flexible endoscope has been introduced through aqueduct
for the evacuation of pontine haemorrhage.
CSF Diversion: External ventricular drain (EVD)
may be required in those cases which develop acute
hydrocephalus after spontaneous ICH. This is especially
true in those cases in which ICH extends into or compresses
the ventricular system. EVD may be life saving in this
situation.31
Recommendations in recent American Heart
Association/American Stroke Association guidelines
suggest that operative removal within 12 hours by less
invasive methods has some benefit. Ultra early craniotomy
(within 12 hours) does not improve functional outcome or
mortality rate and on the other hand is associated with
increased risk of recurrent bleeding. Delayed craniotomy
similarly does not offer any benefit and in fact may worsen
the outcome.32
Surgery may be required to treat less common causes
of haemorrhagic stroke such as spontaneous sub dural
haematoma or extra dural haematoma. Craniotomy is
required for acute and more solid lesions, while burr hole
evacuation is usually sufficient for more liquid and chronic
lesions. In addition, surgery may also play a diagnostic role
e.g. whenever a biopsy is required in cases of ICH due to
vasculitis.
Conclusion
Majority of the stroke patients do not need
neurosurgical involvement but in certain cases where the
patient is deteriorating fast with increased ICP, herniation or
impending herniation, neurosurgery should be immediately
undertaken. Even diseases as devastating as cerebral venous
thrombosis can have a remarkable benefit from surgical
intervention in certain cases.33 Although a lot of
intervention that was done by neurosurgery has been taken
over by interventional radiology, their respective roles have
yet to be defined with high quality studies. 
Neurosurgery plays an important second-tier role in
the management of stroke.  It behoves therefore in tertiary
centres as well as other hospitals for the neurosurgery and
neurology to work together.  Appropriate referral can make
a remarkable difference for the unfortunate victims of
stroke.  In many centres the haemorrhagic stroke patients
are admitted by the neurosurgical service and ischaemic
stroke patients are managed by Neurologists.  Whether this
should be practiced in all the centres or an alternate
arrangement may be agreed upon, depends on the strength
of the neurology and neurosurgical service and their support
staff.  Physical proximity of the neurology and neurosurgery
inpatient beds, clinics and combined academic activity
plays a definitive role in improving the quality of stroke
patient care.
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Review Article
Ischaemic Stroke in Children - Overview Including an Asian Perspective
Mubeen F. Rafay 
Section of Neurology, Department of Pediatrics and Child Health, University of Manitoba, Canada. 
Abstract
Stroke is an important cause of death and disability
in children. Although uncommon in children compared to
adults, childhood stroke is less rare than previously thought.
Improved understanding and advances in neuroimaging
techniques have resulted in improved recognition and
diagnosis of this disorder. Multiple causes and risk factors
contribute to the etiology of stroke in children. The current
review will provide an overview of recent advances in our
understanding of childhood stroke and its implications
during this period of life. In particular, this article will
review the available data from Asian countries. 
Background
For the clinician, the diagnosis of ischaemic stroke
in children is a challenge. Stroke is uncommon in children
and is therefore rarely considered as the first diagnosis when
a child presents with the symptoms. In children, the
presentation is varied; subtle and non-specific that can be
attributed to other neurological disorders such as focal
seizure, Todd's paresis, complicated migraine and
intracranial haemorrhage, demyelination and tumuors. As a
result the diagnosis of ischaemic stroke is often missed or
delayed.  Multiple causative and risk factors contribute to
the etiology of stroke in children, which differ significantly
from those in adults.1 The consequence is lifelong disability
of a significant proportion in the affected children.2 Several
therapeutic interventions including thrombolytic and
neuroprotective therapies have proved to be  effective in
adults with ischaemic stroke, however, to be effective and
safe, these interventions must be instituted within a narrow
therapeutic window (typically within 3-6 hours from
symptom onset).3-5 In children, since disability from stroke
will impact the individual and society for many decades
over their life span compared to adults, the development of
beneficial hyper-acute therapies is of even greater
importance, necessitating prompt and correct stroke
diagnosis.
Although systematic approaches to paediatric stroke
care and research are underway, these are still at very early
stages. In paediatric stroke, randomized controlled studies
are lacking and the available literature is only limited to
case series and population based studies. The majority of
paediatric stroke data is reported from North America and
Europe, largest being the recently completed Canadian
Paediatric Ischaemic Stroke Registry(CPISR). Except few
population studies, data from developing countries largely
comprises of case reports and series.
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